Pickens, S. R., Chamberlain, N. D., Volin, M. V., Gonzalez, M., Pope, R. M., Mandelin, A. M., . . . Shahrara, S. (2011). Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization. Angiogenesis.
Chicago Style CitationPickens, Sarah R., Nathan D. Chamberlain, Michael V. Volin, Mark Gonzalez, Richard M. Pope, Arthur M. Mandelin, Jay K. Kolls, and Shiva Shahrara. "Anti-CXCL5 Therapy Ameliorates IL-17-induced Arthritis By Decreasing Joint Vascularization." Angiogenesis 2011.
MLA CitationPickens, Sarah R., et al. "Anti-CXCL5 Therapy Ameliorates IL-17-induced Arthritis By Decreasing Joint Vascularization." Angiogenesis 2011.
Warning: These citations may not always be 100% accurate.